| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Chorea | |||||
| Drug Induced Dyskinesia | |||||
| Movement Disorder | |||||
| Muscular Disease | |||||
| Tic Disorder | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Disease | |||||
| Dyskinesia, Drug-Induced | |||||
| Dyskinesias | |||||
| Movement Disorders | |||||
| Muscular Diseases | |||||
| Tic Disorders | |||||
| Tics | |||||
| 3 | More general conditions related to this trial | ||||
| Central Nervous System Diseases | |||||
| Disorders of Environmental Origin | |||||
| Drug Toxicity | |||||
| Mental Disorders | |||||
| Mental Disorders Diagnosed in Childhood | |||||
| Musculoskeletal Diseases | |||||
| Nervous System Diseases | |||||
| Neurologic Manifestations | |||||
| Neuromuscular Diseases | |||||
| Neurotoxicity Syndromes | |||||
| Pathologic Processes | |||||
| Poisoning | |||||
| Signs and Symptoms | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Botulinum Toxins | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Dyskinesia Agents | |||||
| Central Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Neurological Disorders and Stroke (NINDS) | |||||
|
